CAPNIA INC |
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
Chart calendar Capnia Inc
5c837b6b8f4946de57.sQyanhYSOeyFURt1chPjJ2-Hu3K1AxT2tyKEzodRykk.1F_3qEx7CbntaW0HS1WiYAuy0wOHamGT2UzstMQCgHHAfdauQ01QhvUJLw~7cde6e0019d9e231f7d4a438b65fd57d
Upcoming events on Capnia Inc
Past events on Capnia Inc
| 2024-03-06 04:05 pm | Q4 2023 Earnings Release |
| 2024-03-04 01:30 pm | TD Cowen Health Care Conference |
| 2024-02-14 11:20 am | Oppenheimer Healthcare Life Sciences Conference |
| 2024-02-08 02:30 pm | Guggenheim Healthcare Talks Biotechnology Conference |
| 2023-11-07 08:00 am | Q3 2023 Earnings Release |
| 2023-10-05 03:00 pm | Foundation for Prader-Willi Research Symposium |
| 2023-09-26 09:00 am | C602 Topline Study Results Call |
| 2023-09-26 08:10 am | Cantor Global Healthcare Conference |
| 2023-08-08 04:05 pm | Q2 2023 Earnings Release |
| 2023-05-25 11:00 am | Annual General Meeting |
| 2023-05-09 04:05 pm | Q1 2023 Earnings Release |
| 2023-04-03 10:10 am | Guggenheim Genomic Medicines and Rare Disease Day - Fireside Chat |
| 2023-03-21 04:05 pm | Q4 2022 Earnings Release |
| 2023-03-14 11:20 am | Oppenheimer Healthcare Conference |
| 2022-11-09 04:05 pm | Q3 2022 Earnings Release |
| 2022-09-11 | H.C. Wainwright Global Investment Conference |
| 2022-08-11 04:05 pm | Interim 2022 Earnings Release |
| 2022-07-05 | International Prader-Willi Syndrome Organisation Conference - Preliminary Findings from the Final Qu |
| 2022-07-05 | International Prader-Willi Syndrome Organisation Conference - Application of a Novel Hybrid Natural |
| 2022-07-05 | International Prader-Willi Syndrome Organisation Conference - Long-Term Safety of Diazoxide Choline |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -23,5 -23,4 -0.53% | -36,3 -36,4 0.17% | -31,5 -36,2 13.02% | -24,4 -25,9 5.92% | -41,4 -36,5 -13.5% | -58,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -30,8 -23,9 -28.62% | -24,6 -28,9 14.6% | -30,9 -35,3 12.4% | -24,1 -25,7 6.37% | -39,0 -36,4 -7.01% | -57,8 |
|
Net income Million USD | Released Forecast Spread | -30,8 -23,4 -31.53% | -24,6 -28,3 12.94% | -30,9 -35,5 12.91% | -24,1 -25,7 6.37% | -39,0 -36,4 -7.01% | -57,8 |
|
EPS USD | Released Forecast Spread | -13,5 -9,98 -35.34% | -5,85 -6,70 12.69% | -5,85 -6,53 10.34% | -2,87 -1,95 -47.18% | -2,36 -2,30 -2.61% | -1,56 |
| Announcement Date | 04/03/20 | 03/03/21 | 31/03/22 | 21/03/23 | 06/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -3,00 -7,73 61.2% | -5,77 -7,10 18.63% | -6,78 -7,10 4.51% | -6,24 -7,48 16.62% | -5,61 -7,14 21.41% | -8,47 -6,89 -23.01% | -8,62 -7,86 -9.74% | -10,4 -7,38 -40.75% | -13,9 -9,39 -48.17% | -13,1 | -13,6 | -14,5 | -17,2 | -13,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -2,83 -7,20 60.74% | -5,72 -6,54 12.41% | -6,73 -6,98 3.68% | -6,13 -7,42 17.39% | -5,49 -7,11 22.88% | -8,36 -6,84 -22.2% | -8,48 -7,83 -8.27% | -10,9 -7,31 -48.61% | -11,3 -9,19 -22.98% | -13,0 | -13,6 | -14,4 | -17,1 | -13,8 |
|
Net income Million USD | Released Forecast Spread | -2,83 -7,40 61.79% | -5,72 -7,02 18.43% | -6,73 -6,98 3.68% | -6,13 -7,42 17.39% | -5,49 -7,11 22.88% | -8,36 -6,84 -22.2% | -8,48 -7,83 -8.27% | -10,9 -7,31 -48.61% | -11,3 -9,19 -22.98% | -13,0 | -13,6 | -14,4 | -17,1 | -13,8 |
|
EPS USD | Released Forecast Spread | -0,60 -1,28 52.94% | -1,05 -1,05 0% | -0,90 -0,90 0% | -0,76 -0,91 16.48% | -0,58 -0,80 27.5% | -0,88 -0,73 -21.38% | -0,81 -0,83 2.02% | -0,95 -0,58 -64.74% | -0,33 -0,26 -27.74% | -0,37 | -0,38 | -0,39 | -0,44 | -0,39 |
| Announcement Date | 31/03/22 | 10/05/22 | 10/08/22 | 09/11/22 | 21/03/23 | 09/05/23 | 08/08/23 | 07/11/23 | 06/03/24 | - | - | - | - | - |
| Today 04:05 pm | EXELIXIS, INC.: Q1 2024 Earnings Release |
| 2024-04-30 | SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release |
| 2024-04-30 | MACROGENICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | REGENXBIO INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | DECIPHERA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-01 07:00 am | NEUROCRINE BIOSCIENCES, INC.: Q1 2024 Earnings Release |
| 2024-05-01 04:05 pm | SAREPTA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-01 | ZENTALIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-01 | DENALI THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-01 | GERON CORPORATION: Q1 2024 Earnings Release |
Past sector events for Capnia Inc
- Stock Market
- Equities
- SLNO Stock
- Stock
- Calendar Capnia Inc
